Ignis Therapeutics

Private

ShanghaiHealthcare & Life Scienceshttps://ignistherapeutics.com/

Last Round

Series A

Nov 11, 2021

Total Funding Raised

$185M

Company Overview

Ignis Therapeutics is a biotechnology company that develops and commercializes innovative therapies for central nervous system (CNS) disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

biotechnologyCNS disorderscentral nervous systemdrug commercializationmedical devicesdrug discoveryclinical developmentin-licensingepilepsy treatmentADHD treatmentbiopharmaAI drug designGreater China marketeTNS systemcomputational drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ignis Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Ignis Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ignis Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Nov 11, 2021

View all Funding Rounds

Ignis Therapeutics Investors

Notable investors and investment history

Ignis Therapeutics investors
Investor	Rounds
KB Investment	Series A
HBM Healthcare Investments	Series A
6 Dimensions Capital	Series A
Mubadala Investment Company	Series A

View all Investors

Ignis Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Ignis Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ignis Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Year Founded2020

Last FundingNov 11, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.